Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib PCR-Monitoring, Adherence, Quality of Life, Therapy Satisfaction

NCT02348957 is registered in ClinicalTrials.gov with Onco Medical Consult GmbH as lead sponsor.

NCT NCT02348957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02348957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib PCR-Monitoring, Adherence, Quality of Life, Therapy Satisfaction
Lead sponsor
Onco Medical Consult GmbH
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
May 31, 2019
Enrollment
223 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid leukemia, chronic, chronic-phase